Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease.

about

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q50203307

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pulmonary Safety and Tolerabil ...... ents with Parkinson's Disease.

@en

Pulmonary Safety and Tolerability of Inhaled Levodopa

@nl

type

Item

label

Pulmonary Safety and Tolerabil ...... ents with Parkinson's Disease.

@en

Pulmonary Safety and Tolerability of Inhaled Levodopa

@nl

prefLabel

Pulmonary Safety and Tolerabil ...... ents with Parkinson's Disease.

@en

Pulmonary Safety and Tolerability of Inhaled Levodopa

@nl

P1476

Pulmonary Safety and Tolerabil ...... ents with Parkinson's Disease.

@en

P2093

Alexander Sedkov

http://www.w3.org/2001/XMLSchema#string

Ann Corbin

http://www.w3.org/2001/XMLSchema#string

Harald Murck

http://www.w3.org/2001/XMLSchema#string

Peter A LeWitt

http://www.w3.org/2001/XMLSchema#string

Richard Batycky

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease

Standardisation of spirometry

Respiratory function in Parkinson's disease.

The scientific and clinical basis for the treatment of Parkinson disease (2009).

Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?

Dry powder inhalers for pulmonary drug delivery.

In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.

Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.

P304

155-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JAMP.2016.1354

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rajesh Pahwa

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29161531

http://www.w3.org/2001/XMLSchema#string

P921

levodopa

P932

5994675

http://www.w3.org/2001/XMLSchema#string